|
Summary
November 2007, Vol. 8, No. 16, Pages 2757-2774
, DOI 10.1517/14656566.8.16.2757
Pharmacotherapy for allergic contact dermatitisSharon E Jacob1University of Miami, Leonard M. Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Florida 33124, USA sjacob@med.miami.edu Allergic contact dermatitis is a highly prevalent, potentially chronic disease, with a significant economic and quality of life impact. Culprit causal allergen(s) can be identified though patch testing, the ‘gold-standard’ diagnostic method. For most people, identification and subsequent avoidance of their clinically relevant allergens will results in resolution of the dermatitis. However, when an avoidance regimen is not possible, or an allergen is not identified, patients potentially require symptomatic and immunosuppressive therapy to diminish the manifestations of their disease. This article reviews a therapeutic approach to allergic contact dermatitis. Forward Links to Citing ArticlesMari Paz Castanedo-Tardan, Mercedes E. González, Elizabeth A. Connelly, Kelly Giordano, Sharon E. Jacob. (2009) Systematized Contact Dermatitis and Montelukast in an Atopic Boy. Pediatric Dermatology Online publication date: 1-Apr-2009. CrossRef |
|





Author for correspondence
TOC Alert